Point-and-Image to Know-the-Flow

Security Type
Non-Voting Equity
Min Investment
Raleigh, NC
Offering Date
January 07, 2022
Expected Close Date
May 29, 2022
Amount Raised
Target Raise
No. Investors
Security Price

Company Description

Scinovia’s mission is to produce state-of-the-art diagnostics to help doctors make more data-driven decisions during procedures to save more lives. Scinovia developed VUFLOW, the future of non-contact imaging diagnostics for blood flow during surgery.


StartEngine OWNERS Exclusive Click here to learn more

$498+ Investment
StartEngine Owner’s Bonus
This offering is eligible for the StartEngine Owner’s 10% Bonus program. For details on this program, please see the Offering Summary section below.

$1,500+ Investment
$1,500+ Tier
Invest $1,500+ and receive 15% bonus shares

$5,000+ Investment
$5,000+ Tier
Invest $5,000+ and receive 20% bonus shares

$25,000+ Investment
$25,000+ Tier
Invest $25,000+ and receive 25% bonus shares

$50,000+ Investment
$50,000+ Tier
Invest $50,000+ and receive 30% bonus shares

$100,000+ Investment
$100,000+ Tier
Invest $100,000+ and receive 40% bonus shares

Key Deal Facts

Save more lives: A big challenge many surgeons face is knowing if procedures have optimal blood flow for quick recovery.
Disrupt a $500M market: Displace legacy contact probe* and dye* methods over past 60 years with VUFLOW, one of the first non-contact measurement device to visualize blood flow speeds in surface vessels during major surgeries.
Platform Technology: VUFLOW may be applicable to many types of surgeries. There are over 300M per year. Initial markets are heart bypass and organ transplants.

Security Description

Non-voting stock is stock that provides the shareholder very little or no vote on corporate matters.

Research Reports

No reports have been submitted

Become a Reporter